Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLegal & General Regulatory News (LGEN)

Share Price Information for Legal & General (LGEN)

Share Price is delayed by 15 minutes
Get Live Data
286.00    1.70 (0.60%)
Bid:
286.60
Ask:
286.80
Spread: 0.20 (0.07%)
Market Cap: £15.67b
LGEN Live PriceLast checked at - London Stock Exchange

Intraday Legal & General Share Chart

Director/PDMR Shareholding

18 Dec 2020 17:00

RNS Number : 2281J
Legal & General Group Plc
18 December 2020
 

Legal & general group plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

 

The following notification made under articles 19.1 and 19.3 of the Market Abuse Regulation ("MAR") relates to:

· the exercise of an award granted on 14 April 2015 under the terms of the Legal & General Group Performance Share Plan 2015 (PSP 2015);

· the exercise of an award granted on 21 April 2016 under the terms of the Legal & General Group Performance Share Plan 2016 (PSP 2016); and

· the exercise of an award granted on 18 April 2017 under the terms of the Legal & General Group Performance Share Plan 2017 (PSP 2017).

The performance conditions attached to the PSP 2015 award provide that the award vests, subject to satisfaction of the performance conditions, after the announcement of the results for 2017 with one third of vested options becoming exercisable immediately, the second third becoming exercisable after the announcement of the 2018 results and the remaining third after the announcement of the 2019 results. PSP 2015 options must be exercised by the seventh anniversary of the date of grant.

The performance conditions attached to the PSP 2016 award provide that the award vests, subject to satisfaction of the performance conditions, after the announcement of the results for 2018 with one third of vested options becoming exercisable immediately, the second third becoming exercisable after the announcement of the 2019 results and the remaining third after the announcement of the 2020 results. PSP 2016 options must be exercised by the seventh anniversary of the date of grant.

The performance conditions attached to the PSP 2017 award provide that the award vests, subject to satisfaction of the performance conditions, after the announcement of the results for 2019 with one third of vested options becoming exercisable immediately, the second third becoming exercisable after the announcement of the 2020 results and the remaining third after the announcement of the 2021 results. PSP 2017 options must be exercised by the seventh anniversary of the date of the grant.

Name

Director/ PDMR

Number of shares awarded on 14 April 2015

Number of shares awarded on 21 April 2016

Number of shares awarded on 18 April 2017

Number of shares exercised on 17 December 2020

Shares sold to cover tax and social security

Shares retained by individual

Kerrigan Procter

PDMR

44,844

 

53,501

 

138,566

236,911

 

111,350

 

125,561

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Kerrigan Procter

2

Reason for the notification

a)

Position/status

Chief Executive Officer, Legal & General Capital/PDMR

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Legal & General Group Plc

b)

LEI

213800JH9QQWHLO99821

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.025 each, with voting rights attached

GB0005603997

b)

Nature of transaction

1. Exercise of PSP 2015 award of nil cost options over 44,844 shares, exercise of PSP 2016 award of nil cost options over 53,501 shares and exercise of PSP 2017 award of nil cost options over 138,566 shares.

2. Sale of 111,350 shares to cover tax and dealing costs (125,561 shares retained).

c)

 

Price(s) and volume(s)

 

Price(s)

Volume

1. Nil cost

1. 236,911

2. £2.587

2. 111,350

d)

Aggregated information

- Aggregated volume

- Price

1. Price

1. Volume

1. Total

1. £0.00

1. 236,911

1. £0.00

2. Price

2. Volume

2. Total

2. £2.587

2. 111,350

2. £288,062.45

e)

Date of the transaction

17 December 2020

f)

Place of the transaction

London Stock Exchange, XLON

 

18 December 2020

 

Daniella Newson

Senior Assistant Company Secretary

Legal & General Group Plc

Tel: 0203 124 2107

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQVLFFBLLLFBV
Date   Source Headline
8th Sep 202511:00 amRNSTender Offer - Final Results
3rd Sep 20257:00 amRNSCompletion of £500m Share Buyback Programme
2nd Sep 20256:15 pmRNSTransaction in Own Shares
2nd Sep 20256:15 pmRNSDirector/PDMR Shareholding
2nd Sep 202511:45 amRNSPublication of Final Terms
1st Sep 20256:15 pmRNSTransaction in Own Shares
1st Sep 20256:15 pmRNSDirector/PDMR Shareholding
1st Sep 20256:15 pmRNSDirector/PDMR Shareholding
1st Sep 20256:15 pmRNSTotal Voting Rights
1st Sep 20254:30 pmRNSHolding(s) in Company
29th Aug 20256:00 pmRNSTransaction in Own Shares
29th Aug 202511:30 amRNSTender Offer - Maximum Acceptance Amount
28th Aug 20255:45 pmRNSTransaction in Own Shares
27th Aug 20255:45 pmRNSTransaction in Own Shares
27th Aug 202512:00 pmRNSRedemption of Debt
27th Aug 20258:40 amRNSTender Offer
26th Aug 20256:00 pmRNSTransaction in Own Shares
22nd Aug 20255:30 pmRNSTransaction in Own Shares
21st Aug 20255:45 pmRNSTransaction in Own Shares
20th Aug 202511:00 amRNSPublication of Supplementary Prospectus
14th Aug 20256:15 pmRNSDirector/PDMR Shareholding
6th Aug 20257:00 amRNSL&G Half Year Results 2025
4th Aug 20256:15 pmRNSDirector/PDMR Shareholding
1st Aug 20256:15 pmRNSDirector/PDMR Shareholding
1st Aug 20256:15 pmRNSDirector/PDMR Shareholding
1st Aug 20256:15 pmRNSTotal Voting Rights
29th Jul 20256:15 pmRNSTransaction in Own Shares
28th Jul 20256:15 pmRNSTransaction in Own Shares
24th Jul 20255:45 pmRNSTransaction in Own Shares
24th Jul 202510:26 amRNSHolding(s) in Company
23rd Jul 20256:00 pmRNSTransaction in Own Shares
22nd Jul 20255:45 pmRNSTransaction in Own Shares
21st Jul 20255:45 pmRNSTransaction in Own Shares
18th Jul 20256:15 pmRNSTransaction in Own Shares
17th Jul 20255:45 pmRNSTransaction in Own Shares
16th Jul 20255:45 pmRNSTransaction in Own Shares
15th Jul 20256:00 pmRNSTransaction in Own Shares
14th Jul 20255:45 pmRNSTransaction in Own Shares
11th Jul 20255:45 pmRNSTransaction in Own Shares
10th Jul 20256:00 pmRNSTransaction in Own Shares
9th Jul 20255:45 pmRNSTransaction in Own Shares
8th Jul 20256:15 pmRNSTransaction in Own Shares
7th Jul 20256:00 pmRNSTransaction in Own Shares
2nd Jul 20256:15 pmRNSDirector/PDMR Shareholding
2nd Jul 20256:15 pmRNSTransaction in Own Shares
2nd Jul 20256:15 pmRNSDirector/PDMR Shareholding
1st Jul 20256:15 pmRNSBlock listing Interim Review
1st Jul 20256:15 pmRNSTransaction in Own Shares
1st Jul 20256:15 pmRNSDirector/PDMR Shareholding
1st Jul 20256:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.